Joining Forces to Prevent the Antibiotic Resistance Doomsday Scenario: The Rise of International Multisectoral Partnerships as a New Governance Model
- 1 November 2020
- journal article
- research article
- Published by Academy of Management in Academy of Management Perspectives
- Vol. 34 (4), 458-479
- https://doi.org/10.5465/amp.2019.0018
Abstract
Humanity is facing a global threat caused by growing antibiotic resistance. If the current lack of innovation in antibiotics persists, we will face a doomsday scenario with drastic implications for society, health, and business worldwide. In this study, we examine international multisectorial partnerships (IMSPs), one of the policy interventions introduced to incentivize the antibiotic innovation necessary to avoid such a scenario. Based on insights from three recently launched antibiotics IMSPs, we present their key features and argue that such partnerships represent a novel type of organizational form and governance, different from others discussed in previous research. Specifically, antibiotics IMSPs are inter-organizational structures showing great governance complexity, strong centralized control, strict boundaries, and formalization of roles and rules. We discuss how antibiotics IMSPs differ from other partnerships dealing for instance with the environmental global challenge and their usefulness in other contexts where similar uncertain, risky, urgent, and complex tasks need to be faced. We conclude with implications for theory as well as for policy and managerial practice, along with avenues for future research.Keywords
This publication has 90 references indexed in Scilit:
- Creating and Capturing Value in Public-Private Ties: A Private Actor's PerspectiveAcademy of Management Review, 2012
- Product development public–private partnerships for public health: A systematic review using qualitative dataSocial Science & Medicine (1982), 2011
- Drug discovery and development for neglected diseases: the DNDi modelDrug Design, Development and Therapy, 2011
- Metatheory of network management: A contingency perspectiveIndustrial Marketing Management, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Rise of strategic nets — New modes of value creationIndustrial Marketing Management, 2007
- Cross-Sector Partnerships to Address Social Issues: Challenges to Theory and PracticeJournal of Management, 2005
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- ”Coopetition” in Business Networks—to Cooperate and Compete SimultaneouslyIndustrial Marketing Management, 2000
- An empirical analysis of factors explaining foreign joint venture performance in ChinaJournal of Business Research, 1996